159 related articles for article (PubMed ID: 25568864)
1. Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?
Gonzalez SA
Hepatobiliary Surg Nutr; 2014 Dec; 3(6):410-4. PubMed ID: 25568864
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
Gonzalez SA; Keeffe EB
Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
5. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.
Caviglia GP; Abate ML; Petrini E; Gaia S; Rizzetto M; Smedile A
Hepatol Res; 2016 Mar; 46(3):E130-5. PubMed ID: 26082262
[TBL] [Abstract][Full Text] [Related]
6. Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review.
Dominguez DA; Wong P; Melstrom LG
Hepatobiliary Surg Nutr; 2024 Feb; 13(1):39-55. PubMed ID: 38322200
[TBL] [Abstract][Full Text] [Related]
7. Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.
Zhao Y; Gao Q; Pei L; Wang C; Jin L; Liao F
Int J Biol Markers; 2017 Oct; 32(4):e361-e369. PubMed ID: 28967065
[TBL] [Abstract][Full Text] [Related]
8. Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.
Setsu T; Tsuchiya A; Watanabe T; Nagoya T; Ikarashi S; Hayashi K; Yokoyama J; Yamagiwa S; Terai S
Case Rep Gastroenterol; 2017; 11(1):142-147. PubMed ID: 28611567
[TBL] [Abstract][Full Text] [Related]
9. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
[TBL] [Abstract][Full Text] [Related]
10. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
[TBL] [Abstract][Full Text] [Related]
12. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
Kudo M
J Gastroenterol Hepatol; 2010 Mar; 25(3):439-52. PubMed ID: 20370723
[TBL] [Abstract][Full Text] [Related]
13. Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet.
Wong GL
World J Hepatol; 2015 Aug; 7(18):2133-5. PubMed ID: 26328024
[TBL] [Abstract][Full Text] [Related]
14. Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
Nomura F; Sogawa K; Noda K; Seimiya M; Matsushita K; Miura T; Tomonaga T; Yoshitomi H; Imazeki F; Takizawa H; Mogushi K; Miyazaki M; Yokosuka O
Biochem Biophys Res Commun; 2012 May; 421(4):837-43. PubMed ID: 22554520
[TBL] [Abstract][Full Text] [Related]
15. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
[TBL] [Abstract][Full Text] [Related]
16. Serum markers of hepatocellular carcinoma.
Spangenberg HC; Thimme R; Blum HE
Semin Liver Dis; 2006 Nov; 26(4):385-90. PubMed ID: 17051452
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
[TBL] [Abstract][Full Text] [Related]
18. Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma.
Maeda T; Kanzaki H; Chiba T; Ao J; Kanayama K; Maruta S; Kusakabe Y; Saito T; Kobayashi K; Kiyono S; Nakamura M; Ogasawara S; Suzuki E; Ooka Y; Nakamoto S; Nakagawa R; Muroyama R; Kanda T; Maruyama H; Kato N
BMC Cancer; 2019 Nov; 19(1):1088. PubMed ID: 31718608
[TBL] [Abstract][Full Text] [Related]
19. Newer markers for hepatocellular carcinoma.
Marrero JA; Lok AS
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S113-9. PubMed ID: 15508074
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
